Orchid Pharma Limited Share Price Bombay S.E.
Equities
524372
INE191A01019
Pharmaceuticals
Sales 2024 | 8.19B 98.23M 7.75B | Sales 2025 * | 10.28B 123M 9.72B | Capitalization | 60.58B 726M 57.27B |
---|---|---|---|---|---|
Net income 2024 | 922M 11.05M 872M | Net income 2025 * | 1.49B 17.82M 1.4B | EV / Sales 2024 | 6.31 x |
Net cash position 2024 | 1.32B 15.84M 1.25B | Net cash position 2025 * | 1.65B 19.76M 1.56B | EV / Sales 2025 * | 5.73 x |
P/E ratio 2024 |
72.1
x | P/E ratio 2025 * |
40.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 30/03/20 |
Director of Finance/CFO | - | 28/06/20 | |
Kapil Dayya
CMP | Compliance Officer | - | 12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 30/03/20 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 30/03/20 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 30/03/20 |
1st Jan change | Capi. | |
---|---|---|
+55.19% | 801B | |
+47.26% | 631B | |
-6.09% | 359B | |
+21.92% | 337B | |
+18.40% | 245B | |
+3.64% | 231B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 161B |